To explain these results, we hypothesize that when melanoma cells are present in the lymph nodes of patients the environment becomes very rich in ETs, thus switching all ETB into an activated state recognized by RB49 and generating intense labeling. The gene discussed is EDNRB; the disease is melanoma.